Compounds > 1,3,4-thiadiazole
Page last updated: 2024-09-03

1,3,4-thiadiazole and Pancreatic Neoplasms

1,3,4-thiadiazole has been researched along with Pancreatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Carbone, D; Cascioferro, S; Diana, P; Giovannetti, E; Panzeca, G; Parrino, B; Pecoraro, C; Roeten, MSF; Xu, G1
Chang, KH; Kumar, D; Maruthi Kumar, N; Shah, K1

Other Studies

2 other study(ies) available for 1,3,4-thiadiazole and Pancreatic Neoplasms

ArticleYear
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1.
    Marine drugs, 2023, Jul-19, Volume: 21, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Humans; Pancreatic Neoplasms

2023
Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:10

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Male; Pancreatic Neoplasms; Prostatic Neoplasms; Structure-Activity Relationship; Thiadiazoles

2010